左心耳閉鎖デバイス市場レポート：2030年までの動向、予測、競合分析

左心耳閉鎖デバイスの動向と予測

世界の左心耳閉鎖デバイス市場は、2024年から2030年までのCAGRが17.7％で、2030年までに推定38億米ドルに達すると予測されます。この市場の主な促進要因は、心房細動（AF）の症例の増加、最先端技術の採用の増加、および世界のライフスタイルの乱れです。世界の左心耳閉鎖デバイス市場の将来は、病院と外来手術センター市場における機会によって有望視されています。

左心耳閉鎖デバイス市場の洞察

Lucintelは、合併症が少なく、入院期間が短く、30日再入院が少ない患者に使用されることから、予測期間中、心内膜がより大きなセグメントであり続けると予測しています。

この市場において、病院は左心房細動（LAA）処置への嗜好の高まりと左心房細動閉鎖デバイスの病院での受け入れ増加により、最大セグメントであり続けると思われます。

北米は、心房細動の増加や高齢化により、引き続き最大の市場です。

本レポートでは、以下の11の主要な質問に回答している：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
• Q.3.今後成長が加速すると思われる地域とその理由は？
• Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
• Q.5.この市場におけるビジネスリスクと競合の脅威は？
• Q.6.この市場における新たな動向とその理由は？
• Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
• Q.8.この市場における新たな開発と、その開発をリードしている企業は？
• Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の左心耳閉鎖デバイス市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の左心耳閉鎖デバイス市場動向（2018～2023年）と予測（2024～2030年）
• 製品別の世界の左心耳閉鎖デバイス市場
  • 心外膜
  • 心内膜
• 最終用途別の世界の左心耳閉鎖デバイス市場
  • 病院
  • 外来手術センター
  • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界の左心耳閉鎖デバイス市場
• 北米の左心耳閉鎖デバイス市場
• 欧州の左心耳閉鎖デバイス市場
• アジア太平洋左心耳閉鎖デバイス市場
• その他地域左心耳閉鎖デバイス市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 製品別の世界の左心耳閉鎖デバイス市場の成長機会
  • 最終用途別の世界の左心耳閉鎖デバイス市場の成長機会
  • 地域別の世界の左心耳閉鎖デバイス市場の成長機会
• 世界の左心耳閉鎖デバイス市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の左心耳閉鎖デバイス市場の能力拡大
  • 世界の左心耳閉鎖デバイス市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Abbott Laboratories
• AtriCure
• Johnson & Johnson
• Aegis Medical
• Cardia
• Biosense Webster
• Sentreheart
• Occlutech
• Boston Scientific Corporation
• Lifetech Scientific Corporation

Left Atrial Appendage Closure Devices Trends and Forecast

The future of the global left atrial appendage closure devices market looks promising with opportunities in the hospitals and ambulatory surgery centers markets. The global left atrial appendage closure devices market is expected to reach an estimated $3.8 billion by 2030 with a CAGR of 17.7% from 2024 to 2030. The major drivers for this market are growing cases of atrial fibrillation (AF), increasing adoption of cutting-edge technologies, and disrupted lifestyle behaviors across the globe.

A more than 150-page report is developed to help in your business decisions.

Left Atrial Appendage Closure Devices by Segment

The study includes a forecast for the global left atrial appendage closure devices by product, end use, and region.

Left Atrial Appendage Closure Devices Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Epicardial
• Endocardial

Left Atrial Appendage Closure Devices Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Ambulatory Surgery Centers
• Others

Left Atrial Appendage Closure Devices Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Left Atrial Appendage Closure Devices Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies left atrial appendage closure devices companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the left atrial appendage closure devices companies profiled in this report include-

• Abbott Laboratories
• Atricure
• Johnson & Johnson
• Aegis Medical
• Cardia
• Biosense Webster
• Sentreheart
• Occlutech
• Boston Scientific Corporation
• Lifetech Scientific Corporation

Left Atrial Appendage Closure Devices Market Insights

Lucintel forecasts that endocardial will remain the larger segment over the forecast period as it is used in patients featured lower complications, shorter hospital stays, and fewer 30-day readmissions.

Within this market, hospitals will remain the largest segment due to growing preference for left atrial appendage (LAA) procedures and an increase in hospital acceptance of left atrial appendage closure devices.

North America iwill remain the largest region due to rising incidences of atrial fibrillation and increasing aging population in the region.

Features of the Global Left Atrial Appendage Closure Devices Market

Market Size Estimates: Left atrial appendage closure devices market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Left atrial appendage closure devices market size by product, end use, and region in terms of value ($B).

Regional Analysis: Left atrial appendage closure devices market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, end uses, and regions for the left atrial appendage closure devices market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the left atrial appendage closure devices market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the left atrial appendage closure devices market size?

Answer: The global left atrial appendage closure devices market is expected to reach an estimated $3.8 billion by 2030.

Q.2 What is the growth forecast for left atrial appendage closure devices market?

Answer: The global left atrial appendage closure devices market is expected to grow with a CAGR of 17.7% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the left atrial appendage closure devices market?

Answer: The major drivers for this market are growing cases of atrial fibrillation (AF), increasing adoption of cutting-edge technologies, and disrupted lifestyle behaviors across the globe.

Q4. What are the major segments for left atrial appendage closure devices market?

Answer: The future of the left atrial appendage closure devices market looks promising with opportunities in the hospital and ambulatory surgery center markets.

Q5. Who are the key left atrial appendage closure devices market companies?

Answer: Some of the key left atrial appendage closure devices companies are as follows:

• Abbott Laboratories
• AtriCure
• Johnson & Johnson
• Aegis Medical
• Cardia
• Biosense Webster
• Sentreheart
• Occlutech
• Boston Scientific Corporation
• Lifetech Scientific Corporation

Q6. Which left atrial appendage closure devices market segment will be the largest in future?

Answer: Lucintel forecasts that endocardial will remain the larger segment over the forecast period as it is used in patients featured lower complications, shorter hospital stays, and fewer 30-day readmissions.

Q7. In left atrial appendage closure devices market, which region is expected to be the largest in next 5 years?

Answer: North America iwill remain the largest region due to rising incidences of atrial fibrillation and increasing aging population in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the left atrial appendage closure devices market by type (epicardial and endocardial), end use (hospitals, ambulatory surgery centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Left Atrial Appendage Closure Devices Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Left Atrial Appendage Closure Devices Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Left Atrial Appendage Closure Devices Market by Product
  • 3.3.1: Epicardial
  • 3.3.2: Endocardial
• 3.4: Global Left Atrial Appendage Closure Devices Market by End Use
  • 3.4.1: Hospitals
  • 3.4.2: Ambulatory Surgery Centers
  • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Left Atrial Appendage Closure Devices Market by Region
• 4.2: North American Left Atrial Appendage Closure Devices Market
  • 4.2.1: North American Left Atrial Appendage Closure Devices Market by Product: Epicardial and Endocardial
  • 4.2.2: North American Left Atrial Appendage Closure Devices Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others
• 4.3: European Left Atrial Appendage Closure Devices Market
  • 4.3.1: European Left Atrial Appendage Closure Devices Market by Product: Epicardial and Endocardial
  • 4.3.2: European Left Atrial Appendage Closure Devices Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others
• 4.4: APAC Left Atrial Appendage Closure Devices Market
  • 4.4.1: APAC Left Atrial Appendage Closure Devices Market by Product: Epicardial and Endocardial
  • 4.4.2: APAC Left Atrial Appendage Closure Devices Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others
• 4.5: ROW Left Atrial Appendage Closure Devices Market
  • 4.5.1: ROW Left Atrial Appendage Closure Devices Market by Product: Epicardial and Endocardial
  • 4.5.2: ROW Left Atrial Appendage Closure Devices Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Left Atrial Appendage Closure Devices Market by Product
  • 6.1.2: Growth Opportunities for the Global Left Atrial Appendage Closure Devices Market by End Use
  • 6.1.3: Growth Opportunities for the Global Left Atrial Appendage Closure Devices Market by Region
• 6.2: Emerging Trends in the Global Left Atrial Appendage Closure Devices Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Left Atrial Appendage Closure Devices Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Left Atrial Appendage Closure Devices Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott Laboratories
• 7.2: AtriCure
• 7.3: Johnson & Johnson
• 7.4: Aegis Medical
• 7.5: Cardia
• 7.6: Biosense Webster
• 7.7: Sentreheart
• 7.8: Occlutech
• 7.9: Boston Scientific Corporation
• 7.10: Lifetech Scientific Corporation